<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR61">
 <label>61.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Holcakova</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Tomasec</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Bugert</surname>
    <given-names>JJ</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>EC</given-names>
   </name>
   <name>
    <surname>Wilkinson</surname>
    <given-names>GW</given-names>
   </name>
   <name>
    <surname>Hrstka</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Krystof</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Strnad</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Vojtesek</surname>
    <given-names>B</given-names>
   </name>
  </person-group>
  <article-title>The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties</article-title>
  <source>Antivir Chem Chemother</source>
  <year>2010</year>
  <volume>20</volume>
  <fpage>133</fpage>
  <lpage>142</lpage>
  <pub-id pub-id-type="doi">10.3851/IMP1460</pub-id>
  <?supplied-pmid 20054100?>
  <pub-id pub-id-type="pmid">20054100</pub-id>
 </element-citation>
</ref>
